Mixing medicine
Patient Safety Monitor, August 15, 2017
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Patient Safety Monitor.
Keeping compounded drugs infection-free
No physician or nurse injects medicine into a patient’s blood planning to make the patient sicker. Sadly, that’s exactly what happened to scores of providers back in 2012. This June, the former president of a Boston compounding pharmacy was sentenced to nine years in prison for racketeering and mail fraud after his company’s products caused a fungal meningitis outbreak, infecting 778 patients nationwide and killing 76.
Many hospitals, clinics, and pharmacies compound their own medicines for a variety of reasons. Sometimes the medicine patients need isn’t available commercially. Sometimes they’re mixed together so the patient only needs one IV instead of having two. Commonly, medicines are mixed into large-volume solutions. And while the Boston case was exceptionally horrific in scope, every compounding facility runs the same risks when trying to compound safe, sterile drugs.
Joint Commission and USP
In January, The Joint Commission unveiled a Medication Compounding Certification (MCC) program that’s open to all compounding pharmacies, not just those accredited by The Joint Commission. The accreditor also called upon healthcare providers to work toward the elimination of medication compounding–related infections (MCRI) like the meningitis outbreak.
“The health care community, including The Joint Commission, recognize that as the need for compounded medications continues to grow it is more important than ever to ensure safe policies and procedures are being appropriately and effectively implemented to prevent patient harm,” wrote Robert Campbell, PharmD, Joint Commission field surveyor, in a blog post.
Meanwhile, the U.S. Pharmacopeial Convention’s (USP) Chapter <800> will become fully enforceable by regulators on July 1, 2018. Its regulations aim to protect the 8 million American healthcare workers who are potentially exposed to hazardous vapors/particles from the substances used in compounding each year. The chapter talks about the physical environment and equipment needed to maintain sterility and avoid inadvertently contaminating the employee. USP also has other extant chapters on sterile compounding, such as Chapters <797> and <795>.
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Patient Safety Monitor.
Related Products
-
Patient Safety Monitor
Patient Safety Monitor is a searchable, web-based crosswalk that organizes state, CMS, and Joint Commission requirements by...
-
Patient Safety Monitor Insider
This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...
-
Patient Safety Monitor - 1 Year Electronic
Patient Safety Monitor is a searchable, web-based crosswalk that organizes state, CMS, and Joint Commission requirements by...
-
Patient Safety Monitor - 1 Year Print and Electronic
Patient Safety Monitor is a searchable, web-based crosswalk that organizes state, CMS, and Joint Commission requirements by...
-
Patient Safety Monitor - 2 Year Electronic
Patient Safety Monitor is a searchable, web-based crosswalk that organizes state, CMS, and Joint Commission requirements by...
Most Popular
- Articles
-
- CMS seeks comment on quality measures
- Don't forget the three checks in medication administration
- Practice the six rights of medication administration
- Know guidelines and subtle differences in code descriptions for laceration repairs
- Nursing responsibilities for managing pain
- Note similarities and differences between HCPCS, CPT® codes
- Steps for maintaining patient privacy
- Prevent dehydration with nursing interventions
- Q&A: Primary, principal, and secondary diagnoses
- Skills of effective case managers
- E-mailed
- Searched